Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1Thromboembolism 1Postoperative Complications 1Neoplasms 1

Interventions

apixaban 5Dalteparin 5edoxaban 2bemiparin 2abelacimab 2Tinzaparin 2Nadroparin 2MAA868 2Heparin, Low-Molecular-Weight 2Enoxaparin 2reviparin 1isoquercitrin 1certoparin 1atezolizumab 1acarboxyprothrombin 1Warfarin 1Rivaroxaban 1Phenprocoumon 1Intermittent Pneumatic Compression Devices 1Fondaparinux 1Dabigatran 1Bevacizumab 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Venous Thrombosis × Fondaparinux × Clear all
NCT00539942 2017-03-27

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

University of Alabama at Birmingham

Phase 3 Terminated
7 enrolled 9 charts

Postoperative Complications, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡